Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
Stock news
SAN FRANCISCO, Nov. 10, 2020 (GLOBE NEWSWIRE) -- Hagens Berman urges Homology Medicines, Inc. (NASDAQ: FIXX) investors with significant losses to submit your losses now. The firm is investigating possible securities fraud and certain investors may have valuable claims. Relevant Period: Before July 21, 2020 Visit: www.hbsslaw.com/investor-fraud/FIXX Contact An Attorney Now: FIXX@hbsslaw.com 844-916-0895Homology Medicines, Inc. (FIXX) Investigation:Homology Medicines is a Boston, MA-based g...
NEW YORK, Nov. 09, 2020 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder law firm, is investigating potential claims against on behalf of investors of Homology Medicines, Inc. (NASDAQ: FIXX), Vasta Platform Limited (NASDAQ: VSTA), Tricida, Inc. (NASDAQ: TCDA), and Energy Harbor Corporation (Other OTC: ENGH). Our investigation concerns whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices. Addition...
Homology Medicines (FIXX) delivered earnings and revenue surprises of 23.46% and 126.80%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
\- Based on Positive Data, Advancing pheNIX Gene Therapy Clinical Trial for PKU to Dose Expansion Phase -\- $60 Million Equity Investment from Pfizer Inc. -\- Unveiled In Vivo Gene Therapy Program for Hunter Syndrome -BEDFORD, Mass., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today financial results for the third quarter ended September 30, 2020, and highlighted recent accomplishments.“At the end of last week, we announced an...
BEDFORD, Mass., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today that Pfizer Inc. (NYSE: PFE) has agreed to make a $60 million equity investment in Homology. Pfizer has agreed to purchase 5,000,000 of Homology’s common stock at a price of $12.00 per share, as part of the Pfizer Breakthrough Growth Initiative, which was announced earlier this year. The purchase by Pfizer is expected to close on or about November 10, 2020. ...
Investors can approximate the average market return by buying an index fund. Active investors aim to buy stocks that...
\- Marked Reductions in Phe Observed at Two Doses - \- Achieved Goal with Plans to Advance to Randomized, Concurrently Controlled Expansion Phase of Trial -\- Webcast / Conference Call Today, November 6 at 4:30 p.m. ET -BEDFORD, Mass., Nov. 06, 2020 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today the presentation of positive data from the dose-escalation portion of the Phase 1/2 gene therapy pheNIX clinical trial for adults with phenylke...